Gaudium IVF IPO Allotment Status Today: GMP, Subscription & How to Check Allotment Online
- 25th February 2026
- 07:00 PM
- 4 min read
Summary
Gaudium IVF and Women Health IPO allotment is expected to be finalised today, February 25. Investors can check their allotment status on the BSE, NSE and registrar Bigshare Services websites. The ₹165 crore IPO was subscribed 7.27 times and is set to list on February 27.Mumbai | February 25
The Gaudium IVF and Women Health IPO allotment is likely to be finalised by late evening today, February 25, following a strong overall subscription of 7.27 times.
With the bidding process now complete, investor focus shifts to checking allotment status and preparing for listing day. The shares are scheduled to debut on the BSE and NSE on February 27, 2026, at 10 am.
The ₹165 crore public issue received bids for 10,63,50,489 shares against 1,46,20,340 shares on offer, according to exchange data.
How to Check Gaudium IVF IPO Allotment Status Online
Investors can check their allotment status on three platforms – BSE, NSE and the registrar, Bigshare Services. You will need basic details such as PAN, application number or DP/Client ID.
Check Allotment Status on BSE
Step 1: Visit the BSE allotment page:
https://www.bseindia.com/investors/appli_check.aspx
Step 2: Select ‘Equity’
Step 3: Choose ‘Gaudium IVF and Women Health Ltd’
Step 4: Enter Application Number or PAN
Step 5: Complete the captcha
Step 6: Click ‘Search’ to view allotment status
Check Allotment Status on NSE
Step 1: Visit the NSE IPO verification page:
https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
Step 2: Select ‘Equity & SME IPO Bid Details’
Step 3: Choose ‘GAUDIUMIVF’ from the symbol list
Step 4: Enter PAN and Application Number
Step 5: Click ‘Submit’ to check status
Check Allotment Status on Bigshare Services (Registrar)
Step 1: Visit the Bigshare IPO allotment page:
www.bigshareonline.com/ipo_Allotment.html
Step 2: Select ‘Gaudium IVF and Women Health’
Step 3: Choose search type; Application No., Beneficiary ID, or PAN
Step 4: Enter the required details
Step 5: Fill captcha and click ‘Search’
Gaudium IVF IPO Subscription Status
The IPO was subscribed 7.27 times overall. Category-wise demand showed strong participation from non-institutional investors.
- Qualified Institutional Buyers (QIBs): 1.62 times
- Non-Institutional Investors (NIIs): 14.05 times
- Retail Individual Investors (RIIs): 7.60 times
While QIB demand remained moderate, strong bidding from NIIs and healthy retail participation supported overall subscription.
Gaudium IVF IPO Key Details
The ₹165 crore IPO consisted of:
- Fresh Issue: ₹90 crore
- Offer for Sale (OFS): ₹75 crore by promoter Dr Manika Khanna
The price band was fixed at ₹75 to ₹79 per share. The lot size for retail investors was 189 shares. Shares will list on February 27, 2026, at 10 am on the BSE and NSE.
Use of Fresh Issue Proceeds
The company plans to use the proceeds for:
- Setting up new IVF centres
- Repayment of certain outstanding loans
- General corporate purposes
About the Company
Gaudium IVF and Women Health provides assisted reproductive technology services in India, focusing on In Vitro Fertilisation (IVF) treatments.
The company operates through a hub-and-spoke model, with seven hubs and 28 spokes across India. This structure allows it to expand reach while centralising specialised services at hub centres.
Gaudium IVF Financial & Business Snapshot
Gaudium IVF has positioned itself in the fast-growing fertility treatment segment in India. Rising awareness, increasing infertility rates and improving access to advanced reproductive technologies have supported industry growth.
The company aims to expand its network footprint and strengthen service offerings through new centre additions.
Gaudium IVF IPO GMP Today
The GMP for Gaudium IVF IPO currently indicates a discount trend. With a cap price of ₹79, the estimated listing price based on the current GMP stands at around ₹77, suggesting a potential discounted debut.
Over the past 13 sessions, GMP has ranged between ₹-2 and ₹15, showing volatility but a recent tilt towards discount territory.
Note: GMP is unofficial grey market data and does not guarantee listing performance.
Stay updated on IPO allotments, listing dates and upcoming public issues with PL Capital.